The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 31, 2020
Filed:
Feb. 28, 2013
Applicant:
Aicuris Gmbh & Co. KG, Wuppertal, DE;
Inventors:
Kerstin Paulus, Ratingen, DE;
Wilfried Schwab, Velbert, DE;
Dominique Grunder, Belp, CH;
Peter Van Hoogevest, Neustadt an der Weinstrasse, DE;
Assignee:
AICURIS GMBH & CO. KG, Wuppertal, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/40 (2006.01); A61K 9/00 (2006.01); A61K 47/18 (2017.01); A61K 31/517 (2006.01); A61K 9/08 (2006.01); C07D 239/84 (2006.01); A61K 47/02 (2006.01); A61K 47/26 (2006.01);
U.S. Cl.
CPC ...
A61K 47/40 (2013.01); A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 31/517 (2013.01); A61K 47/02 (2013.01); A61K 47/183 (2013.01); A61K 47/26 (2013.01); C07D 239/84 (2013.01);
Abstract
The invention relates to pharmaceutical compositions, particularly for intravenous administration, containing {8-fluoro-2-[4-(3-methoxyphenyl)piperazine-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazoline-4-yl}acetic acid in combination with at least one of the cyclodextrin excipients, lysine and arginine; the method for its production; and its use in methods of treatment of and/or as a prophylactic for illnesses, particularly its use as an antiviral, preferably against cytomegaloviruses.